Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer

European Journal of Cancer

Volumn 49, Issue 7, 2013, Pages 1725-1740

  Yamada, Daisaku ^a   Kobayashi, Shogo ^a   Wada, Hiroshi ^a   Kawamoto, Koichi ^a   Marubashi, Shigeru ^a   Eguchi, Hidetoshi ^a   Ishii, Hideshi ^a   Nagano, Hiroaki ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biliary tract cancer; Chemoresistance; Crosstalk; Epithelial mesenchymal transition; Inflammatory cytokine

Indexed keywords

GEMCITABINE; INTERLEUKIN 6; NERVE CELL ADHESION MOLECULE; SMAD4 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CANCER CELL CULTURE; CANCER INVASION; CANCER RESISTANCE; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AGED; BILIARY TRACT NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84876117639     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.12.002     Document Type: Article

References (39)

1. A.X. Zhu, and A.F. Hezel Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities Hepatology 53 2 2011 695 704
2. S. Kobayashi, H. Nagano, and S. Marubashi Treatment of borderline cases for curative resection of biliary tract cancer J Surg Oncol 104 5 2011 499 503
3. J. Valle, H. Wasan, and D.H. Palmer Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 14 2010 1273 1281
4. J.W. Valle Advances in the treatment of metastatic or unresectable biliary tract cancer Ann Oncol 21 Suppl. 7 2010 vii345 vii348
5. S. Kobayashi, H. Nagano, and H. Hoshino Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer J Surg Oncol 103 3 2011 223 229
6. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 6 2002 442 454
7. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 5 2009 871 890
8. A. Blackford, O.K. Serrano, and C.L. Wolfgang SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer Clin Cancer Res 15 14 2009 4674 4679
9. M.H. Yang, C.L. Chen, and G.Y. Chau Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma Hepatology 50 5 2009 1464 1474
10. K. Araki, T. Shimura, and H. Suzuki E/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma Br J Cancer 105 12 2011 1885 1893
11. D. Yamada, S. Kobayashi, and H. Yamamoto Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection Ann Surg Oncol 19 Suppl. 3 2012 355 364
12. S. Kobayashi, N.W. Werneburg, S.F. Bronk, S.H. Kaufmann, and G.J. Gores Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells Gastroenterology 128 7 2005 2054 2065 (Pubitemid 40824713)
13. M. Murakami, S. Kobayashi, and S. Marubashi Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-alpha/5-fluorouracil therapy for hepatocellular carcinoma cells Ann Surg Oncol 18 2 2011 589 596
14. G.J. Gores Cholangiocarcinoma: current concepts and insights Hepatology 37 5 2003 961 969 (Pubitemid 36538671)
15. S. Takiya, T. Tagaya, and K. Takahashi Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases J Clin Pathol 48 12 1995 1093 1097 (Pubitemid 26014847)
16. S.K. Roberts, J. Ludwig, and N.F. Larusso The pathobiology of biliary epithelia Gastroenterology 112 1 1997 269 279 (Pubitemid 27009011)
17. J.S. Goydos, A.M. Brumfield, E. Frezza, A. Booth, M.T. Lotze, and S.E. Carty Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker Ann Surg 227 3 1998 398 404 (Pubitemid 28131021)
18. S. Ohira, K. Itatsu, and M. Sasaki Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma Pathol Int 56 7 2006 381 389 (Pubitemid 43886802)
19. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 6 2010 883 899
20. L.A. Saperstein, R.L. Jirtle, M. Farouk, H.J. Thompson, K.S. Chung, and W.C. Meyers Transforming growth factor-beta 1 and mannose 6-phosphate/insulin- like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat Hepatology 19 2 1994 412 417 (Pubitemid 24046786)
21. G. Shubassi, T. Robert, F. Vanoli, S. Minucci, and M. Foiani Acetylation: a novel link between double-strand break repair and autophagy Cancer Res 72 6 2012 1332 1335
22. J. Park, L. Tadlock, G.J. Gores, and T. Patel Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line Hepatology 30 5 1999 1128 1133 (Pubitemid 29510848)
23. S. Yokomuro, H. Tsuji, and J.G. Lunz 3rd Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells Hepatology 32 1 2000 26 35 (Pubitemid 30432362)
24. S. Yokomuro, J.G. Lunz 3rd, T. Sakamoto, T. Ezure, N. Murase, and A.J. Demetris The effect of interleukin-6 (IL-6)/gp130 signalling on biliary epithelial cell growth, in vitro Cytokine 12 6 2000 727 730 (Pubitemid 30453506)
25. C. Benckert, S. Jonas, and T. Cramer Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells Cancer Res 63 5 2003 1083 1092 (Pubitemid 36278442)
26. F. Meng, Y. Yamagiwa, Y. Ueno, and T. Patel Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes J Hepatol 44 6 2006 1055 1065 (Pubitemid 44308229)
27. P.B. Liton, G. Li, C. Luna, P. Gonzalez, and D.L. Epstein Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells Mol Vis 15 2009 326 334
28. H. Aoki, H. Ohnishi, and K. Hama Existence of autocrine loop between interleukin-6 and transforming growth factor-beta1 in activated rat pancreatic stellate cells J Cell Biochem 99 1 2006 221 228 (Pubitemid 44297966)
29. W. Vanden Berghe, K. De Bosscher, E. Boone, S. Plaisance, and G. Haegeman The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter J Biol Chem 274 45 1999 32091 32098
30. L. Faggioli, C. Costanzo, M. Donadelli, and M. Palmieri Activation of the interleukin-6 promoter by a dominant negative mutant of c-Jun Biochim Biophys Acta 1692 1 2004 17 24 (Pubitemid 38670257)
31. L.R. Luckett-Chastain, and R.M. Gallucci Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice Br J Dermatol 161 2 2009 237 248
32. J. Li, B.J. Tripathi, K.V. Chalam, and R.C. Tripathi Transforming growth factor-beta 1 and -beta 2 positively regulate TGF-beta 1 mRNA expression in trabecular cells Invest Ophthalmol Vis Sci 37 13 1996 2778 2782 (Pubitemid 27026566)
33. A. Kaimori, J.J. Potter, M. Choti, Z. Ding, E. Mezey, and A.A. Koteish Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes Hepatology 52 3 2010 1033 1045
34. K. Hiwatashi, S. Ueno, and M. Sakoda Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular carcinoma Ann Surg Oncol 16 11 2009 3176 3182
35. S. Markowitz, J. Wang, and L. Myeroff Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability Science 268 5215 1995 1336 1338
36. G.J. Riggins, K.W. Kinzler, B. Vogelstein, and S. Thiagalingam Frequency of Smad gene mutations in human cancers Cancer Res 57 13 1997 2578 2580 (Pubitemid 27283760)
37. X. Xu, S. Kobayashi, and W. Qiao Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice J Clin Invest 116 7 2006 1843 1852 (Pubitemid 44033309)
38. J.I. Park, M.G. Lee, and K. Cho Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways Oncogene 22 28 2003 4314 4332 (Pubitemid 36897963)
39. K. Okada, Y. Shimizu, S. Nambu, K. Higuchi, and A. Watanabe Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line J Gastroenterol Hepatol 9 5 1994 462 467 (Pubitemid 24312840)